{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:25:02Z","timestamp":1790277902612,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1283-9","type":"journal-article","created":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T06:36:25Z","timestamp":1437806185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Steroid responsive encephalopathy associated with autoimmune thyroiditis following ipilimumab therapy: a case report"],"prefix":"10.1186","volume":"8","author":[{"given":"David","family":"Carl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Gr\u00fcllich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Hering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,26]]},"reference":[{"key":"1283_CR1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0b013e3182582fd4","volume":"78","author":"M Afshari","year":"2012","unstructured":"Afshari M, Afshari ZS, Schuele SU (2012) Pearls & oy-sters: Hashimoto encephalopathy. Neurology 78:134\u2013137","journal-title":"Neurology"},{"key":"1283_CR2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1196\/annals.1444.018","volume":"1142","author":"N Schiess","year":"2008","unstructured":"Schiess N, Pardo CA (2008) Hashimoto\u2019s encephalopathy. Ann N Y Acad Sci 1142:254\u2013265","journal-title":"Ann N Y Acad Sci"},{"key":"1283_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/CMAR.S31873","volume":"4","author":"S Andrews","year":"2012","unstructured":"Andrews S, Holden R (2012) Characteristics and management of immunerelated adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma. Cancer Manag Res 4:299\u2013307","journal-title":"Cancer Manag Res"},{"key":"1283_CR4","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2012.41.6750","volume":"30","author":"JS Weber","year":"2012","unstructured":"Weber JS, K\u00e4hler KC, Hauschild A (2012) Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol 30:2691\u20132697","journal-title":"J Clin Oncol"},{"key":"1283_CR5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1442-2042.2011.02949.x","volume":"19","author":"M Gakiya","year":"2012","unstructured":"Gakiya M, Naka H, Saito S (2012) Paraneoplastic neurological and haematological syndromes associated with prostate cancer: case report. J Int Urol 19:471\u2013474","journal-title":"J Int Urol"},{"key":"1283_CR6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/iju.12030","volume":"20","author":"JK Jakobsen","year":"2013","unstructured":"Jakobsen JK, Zakharia ER, Boysen AK, Andersen H, Schlesinger FE, Lund L (2013) Prostate cancer may trigger paraneoplastic limbic encephalitis: a case report and a review of the literature. Int J Urol 20:734\u2013737","journal-title":"Int J Urol"},{"issue":"2","key":"1283_CR7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA et al (2002)\u00a0Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87(2):489\u2013499","journal-title":"J Clin Endocrinol Metab"},{"key":"1283_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/EJE-10-0833","volume":"164","author":"L Min","year":"2011","unstructured":"Min L, Vaidya A, Becker C (2011) Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy. Eur J Endocrinol 164:303\u2013307","journal-title":"Eur J Endocrinol"},{"key":"1283_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/IOP.0b013e3181ef72a1","volume":"27","author":"G Borodic","year":"2011","unstructured":"Borodic G, Hinkle DM, Cia Y (2011) Drug-induced Graves\u2019 disease from CTLA-4 receptor suppression. Ophthal Plast Reconstr Surg 27:87\u201388","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"1283_CR10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","volume":"33","author":"RE Royal","year":"2010","unstructured":"Royal RE, Levy C, Turner K, Mathur A, Hughes M, Kammula US et al (2010) Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother 33:828\u2013833","journal-title":"J Immunother"},{"key":"1283_CR11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/practneurol-2012-000447","volume":"13","author":"I Bot","year":"2013","unstructured":"Bot I, Blank CU, Boogerd W, Brandsma D (2013) Neurological immune-related adverse events of ipilimumab. Pract Neurol 13:278\u2013280","journal-title":"Pract Neurol"},{"key":"1283_CR12","unstructured":"European Medicines Agency. Yervoy. EPAR - Product Information. 7\/12 update. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002213\/WC500109299.pdf . Accessed 20 Dec 2012"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1283-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T16:22:36Z","timestamp":1498234956000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1756-0500\/8\/316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,26]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1283-9","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,26]]},"article-number":"316"}}